Literature DB >> 23765605

Dickkopf-3 function in the prostate: implications for epithelial homeostasis and tumor progression.

Diana Romero1, Robert Kypta.   

Abstract

The tumor suppressor Dickkopf-3 (Dkk-3) is rather a unique molecule. Although it is related to the Dickkopf family of secreted Wnt antagonists, it does not directly inhibit Wnt signaling, and its function and mechanism of action are unknown. Endogenous Dkk-3 was recently found to be required to limit cell proliferation both in the developing mouse prostate and in 3D cultures of human prostate epithelial cells. Dkk-3 was further shown to modulate the response of normal prostate epithelial cells to transforming growth factor-β (TGF-β). These studies are consistent with a model in which Dkk-3 is required by normal cells to prevent the TGF-β switch from tumor suppressor to tumor promoter. Here, we discuss these findings and their potential impact on the development and progression of prostate cancer.

Entities:  

Keywords:  Dkk-3; TGF-β; acinar morphogenesis; prostate

Mesh:

Substances:

Year:  2013        PMID: 23765605      PMCID: PMC3715542          DOI: 10.4161/bioa.25243

Source DB:  PubMed          Journal:  Bioarchitecture        ISSN: 1949-0992


  43 in total

Review 1.  Targeting the Wnt pathway in cancer: the emerging role of Dickkopf-3.

Authors:  Jürgen Veeck; Edgar Dahl
Journal:  Biochim Biophys Acta       Date:  2011-09-22

2.  MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma.

Authors:  Bjørn Helge Haug; Jørn R Henriksen; Jochen Buechner; Dirk Geerts; Ellen Tømte; Per Kogner; Tommy Martinsson; Trond Flægstad; Baldur Sveinbjørnsson; Christer Einvik
Journal:  Carcinogenesis       Date:  2011-05-13       Impact factor: 4.944

3.  Reduced expression of REIC/Dkk-3 gene in non-small cell lung cancer.

Authors:  I Nozaki; T Tsuji; O Iijima; Y Ohmura; A Andou; M Miyazaki; N Shimizu; M Namba
Journal:  Int J Oncol       Date:  2001-07       Impact factor: 5.650

4.  Transforming growth factor-beta (TGF-beta)-inducible gene TMEPAI converts TGF-beta from a tumor suppressor to a tumor promoter in breast cancer.

Authors:  Prajjal K Singha; I-Tien Yeh; Manjeri A Venkatachalam; Pothana Saikumar
Journal:  Cancer Res       Date:  2010-07-07       Impact factor: 12.701

5.  Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma.

Authors:  Koji Ueno; Hiroshi Hirata; Shahana Majid; Yi Chen; Mohd S Zaman; Z Laura Tabatabai; Yuji Hinoda; Rajvir Dahiya
Journal:  Mol Carcinog       Date:  2011-01-25       Impact factor: 4.784

6.  Functional epigenomics identifies genes frequently silenced in prostate cancer.

Authors:  Dimitri Lodygin; Alexey Epanchintsev; Antje Menssen; Joachim Diebold; Heiko Hermeking
Journal:  Cancer Res       Date:  2005-05-15       Impact factor: 12.701

7.  Dickkopf-3/REIC functions as a suppressor gene of tumor growth.

Authors:  Sen-Yung Hsieh; Pei-Shan Hsieh; Cheng-Tang Chiu; Wai-Ying Chen
Journal:  Oncogene       Date:  2004-12-09       Impact factor: 9.867

8.  Dkk3 is required for TGF-beta signaling during Xenopus mesoderm induction.

Authors:  Sonia Pinho; Christof Niehrs
Journal:  Differentiation       Date:  2007-05-09       Impact factor: 3.880

Review 9.  Targeting the TGFβ signalling pathway in disease.

Authors:  Rosemary J Akhurst; Akiko Hata
Journal:  Nat Rev Drug Discov       Date:  2012-09-24       Impact factor: 84.694

10.  Dkk3, downregulated in cervical cancer, functions as a negative regulator of beta-catenin.

Authors:  Eun-Ju Lee; Minwha Jo; Seung Bae Rho; Kyoungsook Park; Yae-Na Yoo; Junsoo Park; Myounghee Chae; Wei Zhang; Je-Ho Lee
Journal:  Int J Cancer       Date:  2009-01-15       Impact factor: 7.396

View more
  3 in total

1.  CRISPR-Mediated Reactivation of DKK3 Expression Attenuates TGF-β Signaling in Prostate Cancer.

Authors:  Hoda Kardooni; Estela Gonzalez-Gualda; Emmanouil Stylianakis; Sina Saffaran; Jonathan Waxman; Robert M Kypta
Journal:  Cancers (Basel)       Date:  2018-05-28       Impact factor: 6.639

Review 2.  Apoptotic Pathways Linked to Endocrine System as Potential Therapeutic Targets for Benign Prostatic Hyperplasia.

Authors:  Letteria Minutoli; Mariagrazia Rinaldi; Herbert Marini; Natasha Irrera; Giovanni Crea; Cesare Lorenzini; Domenico Puzzolo; Andrea Valenti; Antonina Pisani; Elena B Adamo; Domenica Altavilla; Francesco Squadrito; Antonio Micali
Journal:  Int J Mol Sci       Date:  2016-08-11       Impact factor: 5.923

3.  Downregulation of C-Terminal Tensin-Like Protein (CTEN) Suppresses Prostate Cell Proliferation and Contributes to Acinar Morphogenesis.

Authors:  Wei-Ming Wu; Yi-Chun Liao
Journal:  Int J Mol Sci       Date:  2018-10-16       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.